GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
400
about 1 year
7–85
28 sites in AR, CA, CO +13
What this study is about
Researchers are testing the safety of a new insulin pump, called NMX8, when used with a continuous glucose monitoring sensor called Disposable Sensor 5 in people with diabetes. The trial will include adults and children with Type 1 or Type 2 diabetes who are 7-85 years old. Participants will use their current therapy while wearing the DS5 for up to 40 days, logging meals and exercise. Then they will be randomly assigned to one of three groups and given the NMX8 pump to use for 90 days, either bolusing or not bolusing for meals depending on the group.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use MiniMed™ NMX8-AID System with DS5™
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endocrinology